Arrowhead Pharmaceuticals (ARWR)
(Delayed Data from NSDQ)
$22.61 USD
+0.08 (0.36%)
Updated Apr 18, 2024 03:59 PM ET
After-Market: $22.64 +0.03 (0.13%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Arrowhead Pharmaceuticals, Inc. [ARWR]
Reports for Purchase
Showing records 41 - 60 ( 89 total )
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Termination of Coverage -Analyst(s) Departure
Provider: DAWSON JAMES SECURITIES, INC.
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Arrowhead Pharmaceuticals, Inc.
Industry: Medical - Drugs
Focus on Nucleotide-based Therapy Positive
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S